{
    "clinical_study": {
        "@rank": "78865", 
        "biospec_descr": {
            "textblock": "Bone Marrow"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "In multiple myeloma \"cancer stem\" cells can be defined and quantified with flow cytometry.\n      More, these cells can be related to treatment response."
        }, 
        "brief_title": "Cancer Stem Cells in Multiple Myeloma", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Myeloma", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal\n      cells that is called \"cancer or progenitor stem cell\". In multiple myeloma to define\n      immunophenotyping features of these \"cancer stem cells\" with flow cytometry and to show\n      their prognostic value and check for any relationship between cancer stem cell\n      quantification and chemotherapy response are main aims of this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  New Diagnosed or Relapsed Multiple Myeloma\n\n          -  Routine Bone Marrow Aspiration will be done\n\n        Exclusion Criteria:\n\n          -  Bone Marrow Aspiration is not Needed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "New Diagnosed or Relapsed Multiple Myeloma Patients"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820546", 
            "org_study_id": "TR06"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 28, 2013", 
        "location": {
            "contact": {
                "email": "kanbilimci@gmail.com", 
                "last_name": "Mehmet Ozen, MD", 
                "phone": "00905362750074"
            }, 
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06590"
                }, 
                "name": "Ankara University Hematology Unit"
            }, 
            "investigator": [
                {
                    "last_name": "Mehmet Ozen, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Meral Beksac, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Osman Ilhan, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells", 
        "overall_contact": {
            "email": "kanbilimci@gmail.com", 
            "last_name": "Mehmet Ozen, MD", 
            "phone": "00905362750074"
        }, 
        "overall_official": {
            "last_name": "Mehmet Ozen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "After 3 courses chemotherapy treatment response", 
            "measure": "Treatment Response", 
            "safety_issue": "Yes", 
            "time_frame": "3 months"
        }, 
        "reference": {
            "PMID": "14630803", 
            "citation": "Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ. Characterization of clonogenic multiple myeloma cells. Blood. 2004 Mar 15;103(6):2332-6. Epub 2003 Nov 20."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820546"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ankara University", 
            "investigator_full_name": "Mehmet Ozen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "After 6 courses chemotherapy treatment response", 
            "measure": "Treatment Response", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "Ankara University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ankara University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}